Alcon AG (ALC)
66.10
-1.80
(-2.64%)
USD |
NYSE |
Jun 10, 16:00
66.10
0.00 (0.00%)
After-Hours: 16:58
Alcon EPS Diluted (Quarterly) : 0.3856 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.3856 |
| December 31, 2025 | 0.4407 |
| September 30, 2025 | 0.4779 |
| June 30, 2025 | 0.3535 |
| March 31, 2025 | 0.7028 |
| December 31, 2024 | 0.5702 |
| September 30, 2024 | 0.5284 |
| June 30, 2024 | 0.4487 |
| March 31, 2024 | 0.4994 |
| December 31, 2023 | 0.8658 |
| September 30, 2023 | 0.411 |
| June 30, 2023 | 0.3409 |
| March 31, 2023 | 0.3512 |
| December 31, 2022 | -0.1972 |
| September 30, 2022 | 0.2345 |
| June 30, 2022 | 0.2994 |
| March 31, 2022 | 0.3401 |
| December 31, 2021 | 0.2813 |
| September 30, 2021 | 0.004 |
| June 30, 2021 | 0.3062 |
| March 31, 2021 | 0.1705 |
| December 31, 2020 | 0.1929 |
| September 30, 2020 | -0.3005 |
| June 30, 2020 | -0.863 |
| March 31, 2020 | -0.1167 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.1864 |
| September 30, 2019 | -0.1352 |
| June 30, 2019 | -0.7988 |
| March 31, 2019 | -0.2233 |
| December 31, 2018 | -0.1494 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.6732 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 0.8995 |
| LENSAR, Inc. | 0.0023 |
| IDEXX Laboratories, Inc. | 3.474 |
| Novartis AG | 1.654 |
| Abbott Laboratories | 0.6165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 189.00M |
| Revenue (Quarterly) | 2.706B |
| Total Expenses (Quarterly) | 2.517B |
| Enterprise Value | 36.72B |
| Gross Profit Margin (Quarterly) | 56.36% |
| Profit Margin (Quarterly) | 6.98% |
| Earnings Yield | 2.51% |
| Operating Earnings Yield | 4.35% |
| Normalized Earnings Yield | 2.775 |